Who is sponsoring NCT02357004?

NCT02357004 is sponsored by University of Alabama at Birmingham.

What condition does NCT02357004 study?

NCT02357004 studies Hypertensive.

What drugs are being tested in NCT02357004?

Interventions: Carvedilol, Chlorthalidone.

What is the status of NCT02357004?

NCT02357004 is currently WITHDRAWN.

Last reviewed 2020-06-10 · How we verify

Mechanisms of Refractory Hypertension (Carvedilol)

NCT02357004 NA WITHDRAWN

The purpose of this protocol is test whether patients with hypertension refractory to antihypertensive treatment have evidence of excessive sympathetic (i.e., nervous system) activity.

Details

Lead sponsor	University of Alabama at Birmingham
Phase	NA
Status	WITHDRAWN
Start date	2015-02
Completion	2020-01-31

Conditions

Hypertensive

Interventions

Carvedilol
Chlorthalidone

Primary outcomes

% of subjects who achieve BP control (<140/90 mm Hg) — 8 weeks after baseline
BP will be measured 8 weeks after starting carvedilol and after starting chlorthaidone. The percent of subjects with BP of \<140/90 mm HG in each group will be reported.